Bank of Montreal Can Has $7.82 Million Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Bank of Montreal Can lowered its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 289,102 shares of the medical instruments supplier’s stock after selling 1,981 shares during the quarter. Bank of Montreal Can owned 0.15% of DENTSPLY SIRONA worth $7,820,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. UMB Bank n.a. grew its stake in DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after acquiring an additional 753 shares in the last quarter. Capital Performance Advisors LLP purchased a new position in DENTSPLY SIRONA during the third quarter valued at approximately $27,000. LRI Investments LLC increased its stake in DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 564 shares during the period. Rothschild Investment LLC purchased a new stake in DENTSPLY SIRONA in the 2nd quarter worth approximately $32,000. Finally, Kennebec Savings Bank acquired a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at $35,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

XRAY has been the subject of several recent research reports. Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Needham & Company LLC cut their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research note on Friday, October 25th. Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Barrington Research cut their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday, November 8th. Finally, StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. Seven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $29.50.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $19.82 on Tuesday. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $37.60. The company has a fifty day simple moving average of $22.43 and a 200 day simple moving average of $24.68. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company has a market cap of $3.94 billion, a P/E ratio of -9.57, a P/E/G ratio of 1.93 and a beta of 0.97.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.49 earnings per share. On average, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.